Soleus Capital Management, L.P. Novo Cure LTD Transaction History
Soleus Capital Management, L.P.
- $1.64 Billion
- Q3 2025
A detailed history of Soleus Capital Management, L.P. transactions in Novo Cure LTD stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 9,644,872 shares of NVCR stock, worth $109 Million. This represents 7.58% of its overall portfolio holdings.
Number of Shares
9,644,872
Previous 6,904,302
39.69%
Holding current value
$109 Million
Previous $123 Million
1.4%
% of portfolio
7.58%
Previous 9.53%
Shares
20 transactions
Others Institutions Holding NVCR
# of Institutions
292Shares Held
74.8MCall Options Held
1.26MPut Options Held
247K-
Black Rock Inc. New York, NY12.1MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$118 Million0.0% of portfolio
-
State Street Corp Boston, MA2.61MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.47MShares$28 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA2MShares$22.6 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.19B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...